Example: Heart Attack

Clinical Trials Sponsored by Pfizer

Total 4744 results

NCT04741997

Recruiting

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Conditions: Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation
NCT03851081

Recruiting

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5 Percent or More of Peripheral Blood White Cells, CD22 Positive, Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells, Lymphoblasts 20 Percent or More of Peripheral Blood White Cells, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
NCT02871791

Active, not recruiting

Palbociclib With Everolimus + Exemestane In BC

Conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor (HR)-Positive Breast Cancer
NCT01356628

Active, not recruiting

A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer

Conditions: Advanced Hepatocellular Carcinoma, HCC, Liver Cancer
NCT03342690

Completed

Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)

Conditions: Chronic Heart Failure
NCT04281485

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy

Conditions: Duchenne Muscular Dystrophy
NCT03416179

Active, not recruiting

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

Conditions: Leukemia, Myeloid, Acute
NCT03031938

Completed

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Conditions: Osteoarthritis, Cancer Pain, Recurrent Low Back Pain
NCT04413617

Recruiting

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Conditions: Rheumatoid Arthritis
NCT03750071

Recruiting

VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma

Conditions: Recurrent Glioblastoma
NCT04937660

Not yet recruiting

Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

Conditions: Metastatic Breast Cancer
NCT04535167

Completed

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

Conditions: Viral Disease
NCT00809354

Terminated

Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

Conditions: Osteoarthritis, Arthritis
NCT04875533

Recruiting

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

Conditions: Pneumococcal Disease
NCT04672460

Recruiting

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Conditions: Advanced Solid Tumors
NCT04821622

Recruiting

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Conditions: Prostate Cancer
NCT04511533

Recruiting

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

Conditions: Metastatic Non Small Cell Lung Cancer
NCT04040621

Recruiting

Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia

Conditions: Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia
NCT04126031

Recruiting

Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.

Conditions: Gram-negative Bacterial Infection
NCT04901702

Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Conditions: Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma, Recurrent Malignant Germ Cell Tumor, Recurrent Malignant Solid Neoplasm, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Peripheral Primitive Neuroectodermal Tumor, Recurrent Rhabdoid Tumor, Recurrent Rhabdomyosarcoma, Recurrent Soft Tissue Sarcoma, Recurrent Wilms Tumor, Refractory Ewing Sarcoma, Refractory Hepatoblastoma, Refractory Malignant Germ Cell Tumor, Refractory Malignant Solid Neoplasm, Refractory Neuroblastoma, Refractory Osteosarcoma, Refractory Peripheral Primitive Neuroectodermal Tumor, Refractory Rhabdoid Tumor, Refractory Rhabdomyosarcoma, Refractory Soft Tissue Sarcoma
NCT03905798

Recruiting

LORA-PITA IV General Investigation

Conditions: Status Epilepticus
NCT02677896

Active, not recruiting

A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Conditions: Metastatic Hormone Sensitive Prostate Cancer
NCT01719380

Completed

Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer

Conditions: Colorectal Cancer
NCT04933799

Recruiting

IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.

Conditions: COVID-19 Pneumonia
NCT04903093

Recruiting

A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.

Conditions: Healthy Volunteers